Tyra Biosciences, Inc.
TYRA
$36.22
$0.220.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.33M | 7.48M | 7.14M | 6.89M | 7.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.52M | 32.94M | 31.45M | 31.85M | 29.74M |
| Operating Income | -36.52M | -32.94M | -31.45M | -31.85M | -29.74M |
| Income Before Tax | -33.83M | -29.87M | -28.10M | -28.15M | -25.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.83M | -29.87M | -28.10M | -28.15M | -25.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.83M | -29.87M | -28.10M | -28.15M | -25.57M |
| EBIT | -36.52M | -32.94M | -31.45M | -31.85M | -29.74M |
| EBITDA | -36.38M | -32.81M | -31.31M | -31.71M | -29.60M |
| EPS Basic | -0.57 | -0.50 | -0.47 | -0.47 | -0.43 |
| Normalized Basic EPS | -0.35 | -0.31 | -0.29 | -0.30 | -0.27 |
| EPS Diluted | -0.57 | -0.50 | -0.47 | -0.47 | -0.43 |
| Normalized Diluted EPS | -0.35 | -0.31 | -0.29 | -0.30 | -0.27 |
| Average Basic Shares Outstanding | 59.83M | 59.67M | 59.55M | 59.34M | 59.06M |
| Average Diluted Shares Outstanding | 59.83M | 59.67M | 59.55M | 59.34M | 59.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |